Alterity Therapeutics (ATHE) Return on Sales (2016 - 2019)

Alterity Therapeutics' Return on Sales history runs 4 years deep, the most recent figure standing at 0.03% for Q4 2019.

• On a quarterly basis, Return on Sales fell 1.0% year-over-year to 0.03% in Q4 2019; TTM through Dec 2019 was 0.05%, a 0.0% change from a year earlier, with the FY2024 full-year figure at 0.04%, changed N/A from the prior year.
• Return on Sales fell to 0.03% in Q4 2019 per ATHE's latest filing, from 0.02% in the prior quarter.
• Across five years, Return on Sales topped out at 0.32% in Q4 2017 and bottomed at 0.03% in Q4 2019.
• The 4-year median for Return on Sales is 0.02% (2018), against an average of 0.06%.
• Across the five-year window, Return on Sales surged 34 bps in 2017 and slumped 34 bps in 2018, its largest moves.
• Year by year, Return on Sales stood at 0.02% in 2016, then soared by 1623 bps to 0.32% in 2017, then plunged by 107 bps to 0.02% in 2018, then sank by 39 bps to 0.03% in 2019.
• Per Business Quant, the three latest ATHE Return on Sales figures stand at 0.03% (Q4 2019), 0.02% (Q4 2018), and 0.32% (Q4 2017).